Charleston Ear, Nose and Throat and SC Launch Company Immunologix, Inc. Team Up to Supply Human Tonsil Tissue for Lifesaving Research

CHARLESTON, SC – August 30, 2010 – Immunologix, Inc,a local biotechnology company and a leader in the production of fullyhuman therapeutic antibodies for a variety of diseases, announced todaythat Charleston Ear, Nose and Throat Associates (Charleston ENT) hasagreed to supply Immunologix, Inc. with human tonsil tissue thatImmunologix will use to produce fully human antibodies.

Immunologix holds the exclusive worldwide license rights to aproprietary technique used to produce fully human antibodies.  After theantibodies are produced for its clients, they will move them throughthe FDA clinical trial and approval process and ideally launch theantibodies into the medical market to save lives and treat a number ofdiseases. 

Immunologix, Inc., is a human antibody discovery and development companyspecializing in transforming naïve B-cells to produce fully humanantibodies that can target any and all antigens including cancer,viruses, bacteria, toxins and auto-immune diseases like diabetes, lupus,rheumatoid arthritis and multiple sclerosis, just to name a few.  Morespecific information about the Immunologix process can be found on theirwebsite at www.ImmunoLogix.com. Immunologix is an SC Launch company.

 The explanted tonsil tissue that Charleston ENT and Immunologixcollect, with patient and parent/guardian consent, would otherwise bediscarded and considered waste.  When a patient between the ages of 3and 12 is scheduled for a tonsillectomy, Charleston ENT will collect thetissue and supply it to Immunologix for processing.  Instead of makingits way to the trash and into biohazard bags, Immunologix capturesbillions of cells from each tonsil and processes them in the Immunologixlaboratory at the new SCRA MUSC Innovation Center at 645 Meeting Streetin Charleston, SC. Space is currently available for lease in theInnovation Center. For more information, please contact John Gregg at803.343.5310.

We are very fortunate to have the support of a local group likeCharleston ENT Associates for this groundbreaking technology.  They are atrue leader in ENT procedures in the greater Charleston area andworking with them is a complete pleasure, said Dr. Ryan Fiorini, (pictured left) Founder and Chief Operating Officer of Immunologix.  The best part ofthis joint effort is that, in lieu of payment, the companies have agreedto donate a designated amount attributable to these procedures to anumber of local and national charities.  

Utilizing sophisticated biotechnology, the techniques used byImmunologix will enable important, innovative medical research andtreatment , said Dave McNamara, SC Launch Executive Director. We areproud to support their efforts, right here in South Carolina from theirlabs at the SCRA MUSC Innovation Center in Charleston.

Charleston Ear, Nose and Throat Associates

Charleston Ear, Nose and Throat Associates, is the largestprivate ENT practice in South Carolina, and continues to lead the way intheir field by providing superior patient care from nine boardcertified physicians within seven different locations, includingCharleston, West Ashley, Summerville, Mount Pleasant, Goose Creek andMonks Corner and at their own Surgery Center dedicated exclusively toENT patients. Visit Charleston ENT online at www.CharlestonENT.com.

SC Launch

SC Launch, an SCRA program, assists entrepreneurialstart-up companies with up-front counseling, seed-funding, and access toa powerful resource network. The SC Launch mission is to help generateknowledge economy jobs in South Carolina, enhance the state’s quality oflife and provide opportunity for all South Carolinians in the neweconomy.  Visit SC Launch online at www.sclaunch.org.

Immunologix is a trademark of Immunologix, Inc.  

Charleston ENT is a registered trademark of Charleston Ear, Nose and Throat Associates.